Acutus Medical, Inc.
Acutus Medical, Inc. (AFIB) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
afib · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Acutus Medical, Inc. (AFIB) measures how much investors pay for each dollar of the company's trailing earnings. AFIB's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.32.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2018 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Acutus Medical, Inc.You AFIB | $0M | N/A | — | -$0.32 |
 Aridis Pharmaceuticals, Inc. ARDS | $0M | N/A | — | -$1.64 |
 Capital Group Holdings, Inc. CGHC | $0M | N/A | — | -$0.01 |
 Evelo Biosciences, Inc. EVLO | $0M | N/A | — | -$26.28 |
 iCoreConnect Inc. ICCT | $0M | N/A | — | -$85.30 |
 Ingen Technologies, Inc. IGNT | $0M | N/A | — | -$0.00 |
 Infinity Pharmaceuticals, Inc. INFIQ | $0M | N/A | — | -$0.50 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-0.32 | — | |
2023-12-31 FY2023 | — | $-2.81 | — | |
2022-12-31 FY2022 | — | $-1.39 | — | |
2021-12-31 FY2021 | — | $-4.11 | — | |
2020-12-31 FY2020 | — | $-8.94 | — | |
2019-12-31 FY2019 | — | $-3.54 | — | |
2018-12-31 FY2018 | — | $-2.84 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Acutus Medical, Inc. (AFIB) measures how much investors pay for each dollar of the company's trailing earnings. AFIB's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.32.
Frequently asked questions
AFIB pe ratio · 6 questionsAFIB's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$0.32. Data sourced from Financial Modeling Prep via AFIB's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Acutus Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08